|
Press Releases |
|
 |
|
Friday, March 21, 2025 |
|
China Medical System (00867) Released its 2024 Annual Results: Focusing on Innovation and Specialty Breakthroughs to Reshape Growth Momentum |
On March 17, China Medical System Holdings Limited ("CMS" or the "Company") released its 2024 annual results. The Company recorded a turnover of RMB7,469 million, representing a year-on-year decrease of 6.8%; in the case that all medicines were directly sold by the Company, the turnover would be RMB8,622 million, representing a year-on-year decrease of 9.0%. more info >> |
|
Friday, February 14, 2025 |
|
China Medical System (867.HK) is Included in the S&P Global Sustainability Yearbook 2025 |
more info >> |
|
China Medical System (867.HK) is Included in the S&P Global Sustainability Yearbook 2025 |
In February 11th 2025, with a Corporate Sustainability Assessment (CSA) score of 61, surpassing 93% of global peers, China Medical System Holdings Limited ("CMS" or the "Group") has been included in the S&P Global Sustainability Yearbook 2025 (the "Yearbook 2025"). more info >> |
|
Friday, January 24, 2025 |
|
China Medical System (00867) Obtained Class 1 Innovative Drug Long-acting Anti-IL-4Ra Monoclonal Antibody MG-K10 |
more info >> |
|
China Medical System (00867) Obtained Class 1 Innovative Drug Long-acting Anti-IL-4Ra Monoclonal Antibody MG-K10 |
China Medical System (00867) Obtained Class 1 Innovative Drug Long-acting Anti-IL-4Ra Monoclonal Antibody MG-K10 more info >> |
|
Thursday, January 9, 2025 |
|
China Medical System (00867) Obtained New Drug ZUNVEYL for the Treatment of Mild-to-Moderate Dementia of the Alzheimer's Type |
China Medical System Holdings Limited (the "Company", together with its subsidiaries, the "Group" or "CMS") is pleased to announce that on 8 January 2025, the Group through a wholly-owned subsidiary of the Company entered into a License, Collaboration and Distribution Agreement (the "Agreement") with Alpha Cognition Inc. ("Alpha") of the improved new drug ZUNVEYL (benzgalantamine delayed-release tablets)("ZUNVEY" or the "Product") for the treatment of mild-to-moderate dementia of the Alzheimer's type. more info >> |
|
China Medical System (00867) Obtained New Drug ZUNVEYL for the Treatment of Mild-to-Moderate Dementia of the Alzheimer's Type |
China Medical System Holdings Limited (the "Company", together with its subsidiaries, the "Group" or "CMS") is pleased to announce that on 8 January 2025, the Group through a wholly-owned subsidiary of the Company entered into a License, Collaboration and Distribution Agreement (the "Agreement") with Alpha Cognition Inc. ("Alpha") of the improved new drug ZUNVEYL (benzgalantamine delayed-release tablets)("ZUNVEY" or the "Product") for the treatment of mild-to-moderate dementia of the Alzheimer's type. more info >> |
|
Monday, December 9, 2024 |
|
China Medical System: First Prescriptions for Innovative Drug Lumeblue(R) Issued in China |
China Medical System: First Prescriptions for Innovative Drug Lumeblue(R) Issued in China more info >> |
|
China Medical System: First Prescriptions for Innovative Drug Lumeblue(R) Issued in China |
China Medical System: First Prescriptions for Innovative Drug Lumeblue(R) Issued in China more info >> |
|
Monday, December 2, 2024 |
|
China Medical System Gained Exclusive Commercialization Right of Class 1 Innovative Drug Targeting Gout and Hyperuricemia |
China Medical System Gained Exclusive Commercialization Right of Class 1 Innovative Drug Targeting Gout and Hyperuricemia more info >> |
|
|
|
|
|
|
|
|
Latest Press Releases |
|
Eisai Satisfies All-Case Surveillance Requirement for Anticancer Agent Remitoro
May 16, 2025 17:21 JST
|
|
|
Premiere of New bZ Woodland BEV Focused on Driving Performance and Spaciousness in North America
May 16, 2025 16:35 JST
|
|
|
Mitsubishi Heavy Industries Activates New Driving Force for Data Center Business in the United States
May 16, 2025 15:43 JST
|
|
|
PCG Powers Hong Kong's Mega-Event Economy and Participates in InnoEX 2025
May 16, 2025 13:23 HKT/SGT
|
|
|
交易寶助力香港盛事經濟及亮相InnoEX 2025
May 16, 2025 13:08 HKT/SGT
|
|
|
交易宝助力香港盛事经济及亮相InnoEX 2025
May 16, 2025 12:40 HKT/SGT
|
|
|
TruMerit 讚揚世界衛生組織發布《世界護理現況報告》
May 16, 2025 11:30 HKT/SGT
|
|
|
Spiritual Business Guide 'Zen and Stilettos' Sells 100,000 Copies, Enters Publisher's Top-10
May 16, 2025 08:00: JST
|
|
|
Spiritual Business Guide 'Zen and Stilettos' Sells 100,000 Copies, Enters Publisher's Top-10
May 16, 2025 07:00 HKT/SGT
|
|
|
TruMerit Hails Release of WHO's State of the World's Nursing Report
May 16, 2025 07:00 HKT/SGT
|
|
|
Euro Manganese Announces Results of Annual General and Special Meeting
May 16, 2025 06:29 HKT/SGT
|
|
|
MHI Thermal Systems Receives JSRAE Technology Award
May 15, 2025 20:08 JST
|
|
|
全球運動品牌 U.S. Polo Assn. 在阿根廷推出男裝系列
May 15, 2025 19:00 HKT/SGT
|
|
|
Global Sports Brand U.S. Polo Assn. Launches Menswear in Argentina
May 15, 2025 19:00 HKT/SGT
|
|
|
全球运动品牌 U.S. Polo Assn. 在阿根廷推出男装系列
May 15, 2025 19:00 HKT/SGT
|
|
|
|
More News >> |
|
|
|
|
|